Xiaofeng Chen
Impact in
- Cancer Research top 5%
- Cancer Genomics and Diagnostics
- Cancer-related molecular mechanisms research
- Oncology top 5%
- Cancer Immunotherapy and Biomarkers
- Pancreatic and Hepatic Oncology Research
- Colorectal Cancer Treatments and Studies
Papers in
-
- Gastric Cancer Management and Outcomes 25
- Lung Cancer Treatments and Mutations 10
- Oncology 41
- Colorectal Cancer Treatments and Studies 10
- Cancer Immunotherapy and Biomarkers 7
- Peptidase Inhibition and Analysis 7
- Co-authors
- Yongmei Yin (9 shared papers)Yongqian Shu (20 shared papers)Yiqian Liu (8 shared papers)Yongqian Shu (3 shared papers)Jinrong Qiu (7 shared papers)Yanhong Gu (18 shared papers)Lingjun Zhu (4 shared papers)Oluf Dimitri Røe (8 shared papers)
- Journals
- Journal of Clinical Oncology (11 papers)OncoTargets and Therapy (4 papers)Biomedicine & Pharmacotherapy (4 papers)Scientific Reports (3 papers)Medicine (3 papers)
- Partner nations
- ChinaNorwayUnited States
In The Last Decade
Xiaofeng Chen
82 papers receiving 1.2k citations
Peers
Comparison fields: 5 of 97
- Cancer Research 319
- Oncology 520
- Toxicology 45
- Pulmonary and Respiratory Medicine 424
- Pathology and Forensic Medicine 128
Countries citing papers authored by Xiaofeng Chen
This map shows the geographic impact of Xiaofeng Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaofeng Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaofeng Chen more than expected).
Fields of papers citing papers by Xiaofeng Chen
This network shows the impact of papers produced by Xiaofeng Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaofeng Chen. The network helps show where Xiaofeng Chen may publish in the future.
Co-authors
The 25 scholars most cited alongside Xiaofeng Chen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 87 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2017 | 144 | |
| 2 | 2020 | 58 | |
| 3 | 2023 | 54 | |
| 4 | 2013 | 50 | |
| 5 | 2013 | 50 | |
| 6 | 2020 | 49 | |
| 7 | 2009 | 44 | |
| 8 | 2019 | 42 | |
| 9 | 2018 | 41 | |
| 10 | 2012 | 40 | |
| 11 | 2013 | 40 | |
| 12 | 2019 | 36 | |
| 13 | 2022 | 32 | |
| 14 | 2014 | 28 | |
| 15 | 2014 | 25 | |
| 16 | 2019 | 23 | |
| 17 | 2015 | 20 | |
| 18 | 2015 | 19 | |
| 19 | 2015 | 19 | |
| 20 | 2015 | 18 |
About Xiaofeng Chen
Xiaofeng Chen is a scholar working on Pulmonary and Respiratory Medicine, Oncology, Surgery, Molecular Biology and Pathology and Forensic Medicine, having authored 87 papers that have together received 1.2k indexed citations. Recurring topics across this work include Gastric Cancer Management and Outcomes (25 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (14 papers), Colorectal Cancer Treatments and Studies (10 papers), Lung Cancer Treatments and Mutations (10 papers), Esophageal Cancer Research and Treatment (8 papers), Gastrointestinal Tumor Research and Treatment (7 papers), Cancer Immunotherapy and Biomarkers (7 papers) and Peptidase Inhibition and Analysis (7 papers). The work is most often cited by research in Cancer Research (319 citations), Oncology (520 citations), Toxicology (45 citations), Pulmonary and Respiratory Medicine (424 citations) and Pathology and Forensic Medicine (128 citations). Xiaofeng Chen has collaborated with scholars based in China, Norway and United States. Frequent co-authors include Yongmei Yin, Yongqian Shu, Yiqian Liu, Yongqian Shu, Jinrong Qiu, Yanhong Gu, Lingjun Zhu, Oluf Dimitri Røe, Yingying Qian and Yang Shao. Their work appears in journals such as Journal of Clinical Oncology, OncoTargets and Therapy, Biomedicine & Pharmacotherapy, Scientific Reports and Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.